Question

A 66-year-old man with a new diagnosis of Parkinson's disease is experiencing symptoms that are impacting his quality of life. He has no significant cognitive impairment. According to NICE NG71, which of the following is a recommended first-line treatment option to manage his motor symptoms?

Accepted Answer

Co-beneldopa (Levodopa + benserazide)

Answer

Levodopa

Answer

Dopamine agonist (e.g., ropinirole)

Answer

MAO-B inhibitor (e.g., rasagiline)

Answer

Amantadine

Practice question

A 66-year-old man with a new diagnosis of Parkinson's disease is experiencing symptoms that are impacting his quality of life. He has no significant cognitive impairment. According to NICE NG71, which of the following is a recommended first-line treatment option to manage his motor symptoms?